SHINE to Present at Piper Jaffray Healthcare Conference

2017-09-18T13:58:17+00:00

November 17, 2016 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 28th Annual Piper Jaffray Healthcare Conference in New York.

SHINE to Present at Piper Jaffray Healthcare Conference 2017-09-18T13:58:17+00:00

SHINE to Present at Mo-99 Topical Meeting

2017-08-01T08:36:30+00:00

September 6, 2016 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 2016 Mo-99 Topical Meeting hosted by the Department of Energy’s National Nuclear Security Administration (DOE/NNSA).

SHINE to Present at Mo-99 Topical Meeting 2017-08-01T08:36:30+00:00

NRC Issues SHINE Construction Permit

2017-10-16T08:36:46+00:00

February 25, 2016 - SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements, announced today that the U.S. Nuclear Regulatory Commission (NRC) has authorized issuance of the SHINE construction permit.

NRC Issues SHINE Construction Permit 2017-10-16T08:36:46+00:00

SHINE Holds 2nd 2015 Community Meeting

2017-08-01T08:40:34+00:00

December 7, 2015 - SHINE invites the Janesville community to an update on the development of its medical isotope production facility. Since our last meeting in June, SHINE’s primary regulator, the Nuclear Regulatory Commission, has completed their safety and environmental reviews and recommended the approval of a Construction Permit for the SHINE facility.

SHINE Holds 2nd 2015 Community Meeting 2017-08-01T08:40:34+00:00

SHINE Achieves Major Milestone on Path to Construction Permit Approval

2017-07-31T18:53:28+00:00

October 26, 2015 - SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements, announced today that the staff of its primary regulator, the Nuclear Regulatory Commission (NRC), has completed their safety and environmental reviews and recommends approval of a Construction Permit for the SHINE facility.

SHINE Achieves Major Milestone on Path to Construction Permit Approval 2017-07-31T18:53:28+00:00